Infliximab Product Approval Info - Licensing Action

Proper name: Infliximab
Tradename: Remicade
Manufacturer: Centocor, Inc, Malvern, PA, License #1242
Indication for Use: Reduction in signs and symptoms of rheumatoid arthritis in patients who have had an inadequate response to methotrexate
Approval Date: 11/10/99
Type of submission: Biologics license application supplement


Approval Letter (PDF)

Label (PDF)

Statistical Review (PDF)

Pharmacology Review (PDF)

Clinical Pharmacology Review (PDF)

Clinical Review (PDF)

Page Last Updated: 05/04/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English